Alembic Pharmaceuticals LimitedNSE: APLLTD

Press Release Jan 27 2026

· Issued by Alembic Pharmaceuticals Limited

Filed with NSE · · 2 pages · English

On 6ix: 6ix.com/news/press-release-jan-27-2026-12

Release

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 27, 2026, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Difluprednate Ophthalmic Emulsion, 0.05%.".

Alembic Pharmaceuticals Limited on 6ix

Earlier from Alembic Pharmaceuticals

Later from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases